Cancer therapeutic agent comprising anti-HB-EGF antibody as active ingredient

Details for Australian Patent Application No. 2007311946 (hide)

Owner Forerunner Pharma Research Co., Ltd.

Inventors Kimura, Naoki

Agent FB Rice

Pub. Number AU-A-2007311946

PCT Pub. Number WO2008/047914

Priority 2006-286824 20.10.06 JP

Filing date 19 October 2007

Wipo publication date 24 April 2008

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/047914 Priority application(s): WO2008/047914

4 June 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Anti-cancer agent comprising anti-HB-EGF antibody as active ingredient

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007311957-Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient

2007311917-The manufacturing method of construction materials using waterworks sludge